Literature DB >> 1812305

The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.

Y Kameyama1, M Gemba.   

Abstract

We evaluated the effect of the iron chelator deferoxamine on lipid peroxidation produced by the nephrotoxic antineoplastic drug cisplatin in rat kidney cortical slices. The addition of deferoxamine to the incubation medium prevented such lipid peroxidation in the incubated slices. Treatment of rats with deferoxamine inhibited the increase in lipid peroxidation caused by cisplatin in the medium. These results suggest that iron may be a causal agent of cisplatin-induced lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812305     DOI: 10.1254/jjp.57.259

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.

Authors:  Eikan Mishima; Emiko Sato; Junya Ito; Ken-Ichi Yamada; Chitose Suzuki; Yoshitsugu Oikawa; Tetsuro Matsuhashi; Koichi Kikuchi; Takafumi Toyohara; Takehiro Suzuki; Sadayoshi Ito; Kiyotaka Nakagawa; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2019-11-25       Impact factor: 10.121

2.  Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide.

Authors:  Kavita K Kumari; O H Setty
Journal:  J Bioenerg Biomembr       Date:  2012-02-24       Impact factor: 2.945

3.  Regulated cell death in cisplatin-induced AKI: relevance of myo-inositol metabolism.

Authors:  Fei Deng; Xiaoping Zheng; Isha Sharma; Yingbo Dai; Yinhuai Wang; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.